Study) among adults with intellectual disability, Brisbane (medicines use reported for 117/138 RCT participants) Community-based studies Callaly187 Audit of 792 April Conventional patients 1999 oral + atypical managed by oral: 19 (3%) a regional Conventional community depot + mental health atypical oral: 9 service, (2%) Victoria. Two oral (n=572 taking atypical an antipsychotics: antipsychotic) 5 (1%) Bains14 Audit of 40 unknown 8 (20%) received conventional patients from + oral three atypical supervised antipsychotics group homes in the community. Treatment resistance not defined Lowe Audit of 38 Jan 9 (24%) patients 1998 – receiving March intensive 2003 case management from a community mental health centre in Melbourne. Patients received ≥52 contacts with the service yearly
Study) among adults with intellectual disability, Brisbane (medicines use reported for 117/138 RCT participants) Community-based studies Callaly187 Audit of 792 patients managed by a regional community mental health service, Victoria. (n=572 taking an antipsychotic) April 1999 Conventional oral + atypical oral: 19 (3%) Conventional depot + atypical oral: 9 (2%) Two oral atypical antipsychotics: 5 (1%) Bains14 Audit of 40 patients from three supervised group homes in the community. Treatment resistance not defined unknown 8 (20%) received conventional + oral atypical antipsychotics Lowe Audit of 38 patients receiving intensive case management from a community mental health centre in Melbourne. Patients received ≥52 contacts with the service yearly Jan 1998 – March 2003 9 (24%)